When Your Study Focuses on Recovery and Sleep Quality Imagine your research is exploring more subtle, long-term anti-aging benefits
Download the Notable Articles of 2025: nej.md/3L4ot87 In the phase 3 ACHIEVE-1 trial, published in June 2025, the oral small-molecule GLP-1 receptor agonist orforglipron significantly reduced the glycated hemoglobin level over a period of 40 weeks in adults with early type 2 diabetes
While glutamate is necessary for learning and memory, too much of it can be taxing on the brain
The applicant stated that it is only seeking a new device category for transitional pass-through payment status for the SCOUT MD TM Delivery System component of the SCOUT MD TM Surgical Guidance System
ARCHITECT System Operations Manual 201837-113 - 2016-04-29 (Abbott Park, IL 60064 USA2016)
7f), suggesting that 3G10 exerts neutralization via steric hindrance of PVR binding